These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17434253)

  • 41. Clinical outcome of radical cystectomy for patients with pT4 bladder cancer.
    Furukawa J; Miyake H; Hara I; Takenaka A; Fujisawa M
    Int J Urol; 2008 Jan; 15(1):58-61. PubMed ID: 18184174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnosis, risk factors, and outcome of urethral recurrences following radical cystectomy for bladder cancer in 729 male patients.
    Huguet J; Monllau V; Sabaté S; Rodriguez-Faba O; Algaba F; Palou J; Villavicencio H
    Eur Urol; 2008 Apr; 53(4):785-92 discussion 792-3. PubMed ID: 17629611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome.
    Tilki D; Reich O; Karakiewicz PI; Novara G; Kassouf W; Ergün S; Fradet Y; Ficarra V; Sonpavde G; Stief CG; Skinner E; Svatek RS; Lotan Y; Sagalowsky AI; Shariat SF
    Eur Urol; 2010 Jul; 58(1):112-7. PubMed ID: 20097469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
    Granfors T; Tomic R; Ljungberg B
    Scand J Urol Nephrol; 2009; 43(4):293-9. PubMed ID: 19363744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prognosis of local recurrence after radical cystectomy for bladder cancer].
    Fukuta F; Honma I; Muto M; Masumori N; Tsukamoto T
    Hinyokika Kiyo; 2009 Aug; 55(8):469-73. PubMed ID: 19764530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Frequency and stage of relapse after organ-saving combined treatment for urinary bladder cancer].
    Nabruzov SN; Vakhabov OU
    Vopr Onkol; 2008; 54(5):636-8. PubMed ID: 19069481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center.
    Kotwal S; Choudhury A; Johnston C; Paul AB; Whelan P; Kiltie AE
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):456-63. PubMed ID: 17904301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Editorial comment on: detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience.
    Dalbagni G
    Eur Urol; 2010 May; 57(5):849. PubMed ID: 19524355
    [No Abstract]   [Full Text] [Related]  

  • 49. Radical cystectomy--often too late? Yes, but ..
    Studer UE
    Eur Urol; 2006 Dec; 50(6):1129-38. PubMed ID: 16949199
    [No Abstract]   [Full Text] [Related]  

  • 50. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL; Lin DW; Porter MP
    Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oncological and functional outcome of radical cystectomy in patients with bladder cancer and obstructive uropathy.
    Gupta NP; Kolla SB; Seth A; Hemal AK; Dogra PN; Kumar R
    J Urol; 2007 Oct; 178(4 Pt 1):1206-11; discussion 1211. PubMed ID: 17698145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
    Herrmann E; Stöter E; van Ophoven A; Bierer S; Bolenz C; Hertle L; Wülfing C
    Int J Urol; 2008 Jul; 15(7):607-11. PubMed ID: 18462352
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mixed high and low grade bladder tumors--are they clinically high or low grade?
    Gofrit ON; Pizov G; Shapiro A; Duvdevani M; Yutkin V; Landau EH; Zorn KC; Hidas G; Pode D
    J Urol; 2014 Jun; 191(6):1693-6. PubMed ID: 24316096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radical therapy for muscle-infiltrating bladder cancer (cystectomy or radiotherapy): does age affect the final therapeutic benefit for the patient?
    Kalogeras D; Lampri E; Goussia A; Bai M; Capizzello A; Tassiou I; Stavropoulos NE; Tsekeris P
    J BUON; 2008; 13(3):353-8. PubMed ID: 18979549
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thoughts on delaying cystectomy.
    Hautmann RE
    Eur Urol; 2006 Dec; 50(6):1151-2. PubMed ID: 16820259
    [No Abstract]   [Full Text] [Related]  

  • 56. The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy.
    Lambert EH; Pierorazio PM; Olsson CA; Benson MC; McKiernan JM; Poon S
    BJU Int; 2007 Jul; 100(1):33-6. PubMed ID: 17552951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome.
    Nielsen ME; Palapattu GS; Karakiewicz PI; Lotan Y; Bastian PJ; Lerner SP; Sagalowsky AI; Schoenberg MP; Shariat SF
    BJU Int; 2007 Nov; 100(5):1015-20. PubMed ID: 17784888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Positive margins in urological oncology.
    Koch MO
    J Urol; 2007 Dec; 178(6):2249. PubMed ID: 17936808
    [No Abstract]   [Full Text] [Related]  

  • 59. Radical cystectomy and lymphadenectomy for invasive bladder cancer: towards the evolution of an optimal surgical standard.
    Raj GV; Bochner BH
    Semin Oncol; 2007 Apr; 34(2):110-21. PubMed ID: 17382794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radical cystectomy for bladder cancer: morbidity of laparoscopic versus open surgery.
    Guillotreau J; Gamé X; Mouzin M; Doumerc N; Mallet R; Sallusto F; Malavaud B; Rischmann P
    J Urol; 2009 Feb; 181(2):554-9; discussion 559. PubMed ID: 19084856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.